DBV Technologies | Der Umsatz



Sales Veränderung Datum
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amarin USD 42.3M 25.19M 2024-09
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
DBV Technologies USD 560K 512K 2024-12
Halozyme Therapeutics USD 298.01M 7.92M 2024-12
Incyte USD 1.05B 128.7M 2025-03
Insmed USD 104.44M 11.02M 2024-12
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
United Therapeutics USD 794.4M 58.5M 2025-03



DBV Technologies Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.